TickerFacts.

Company research / SLGL

Sol-Gel Technologies Ltd. (SLGL)

Build a valuation ↗↓ Download CSV

CIK 0001684693 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Sol-Gel Technologies Ltd. reported revenue of $19.39M. Revenue grew 68.0% from the prior annual period.

Key ratios (year ended 2025-12-31)

-38.9%
Operating margin
-31.6%
Net margin
-26.9%
Return on year-end equity
68.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-10-06

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Stock splits: 1-for-10, first reflected in a filing dated 2025-08-15. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$19.39M$11.54M$1.55M$3.88M$31.27M$8.77M$22.90M$129.0K$174.0Kn/a
R&D Expense$22.80M$17.80M$23.54M$12.68M$20.38M$27.91M$40.58M$28.15M$25.80M$17.02M
Operating Income-$7.54M-$12.01M-$29.30M-$16.24M$2.96M-$30.23M-$25.95M-$33.52M-$31.63M-$20.76M
Depreciation & Amortization$109.0K$233.0K$342.0K$562.0K$880.0K$946.0K$887.0K$762.0K$471.0K$359.0K
EBITDA-$7.43M-$11.78M-$28.96M-$15.68M$3.84M-$29.29M-$25.06M-$32.76M-$31.16M-$20.40M
Net Income-$6.13M-$10.58M-$27.24M-$14.92M$3.22M-$29.29M-$24.61M-$32.20M-$31.57M-$20.77M
EPS (Diluted)-$2.19-$3.79-$10.01-$0.65$0.14-$1.30-$1.26n/an/an/a
Total Assets$29.92M$35.85M$45.29M$46.63M$69.19M$59.16M$61.30M$69.68M$15.31M$10.98M
Total Liabilities$7.11M$7.00M$6.64M$4.42M$13.60M$8.31M$8.84M$5.77M$68.01M$42.32M
Shareholders' Equity$22.81M$28.85M$38.64M$42.21M$55.59M$50.85M$52.47M$63.91M-$52.70M-$31.34M
Cash & Equivalents$11.03M$19.49M$7.51M$12.45M$20.09M$7.12M$9.41M$5.33M$5.02M$7.00M
Operating Cash Flow$322.0K-$13.89M-$17.73M-$9.48M-$7.69M-$25.24M-$22.50M-$23.47M-$24.09M-$18.50M
Capital Expenditures$47.0K$2.0K$134.0K$171.0K$143.0K$449.0K$597.0K$1.05M$1.93M$385.0K
Free Cash Flow$275.0K-$13.89M-$17.86M-$9.65M-$7.83M-$25.69M-$23.10M-$24.52M-$26.01M-$18.88M
Shares Outstanding2.79M2.79M27.86M23.13M23.13M23.00M20.40M18.95M6.29M6.29M
Weighted Average Diluted Shares2.79M2.79M2.71M23.13M23.57M22.57M19.53Mn/an/an/a
EPS (Basic)-$2.19-$3.79-$10.01-$0.65$0.14-$1.30-$1.26n/an/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView